Free press releases distribution network?

More news: Government/B2G
Agency / Source: Iowa City Area Development Group

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



KemPharm Launches Oral Film Dosage for ADHD - KemPharm enters collaboration with MonoSol Rx to co-develop and commercialize KP106
KemPharm Launches Oral Film Dosage for ADHD

 

PRZOOM - /newswire/ - Iowa City, IA, United States, 2011/04/26 - KemPharm enters collaboration with MonoSol Rx to co-develop and commercialize KP106.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Government/B2G Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

KemPharm, Inc. announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder (ADHD), will be formulated and developed in an oral film dosage form pursuant to an exclusive collaboration agreement with MonoSol Rx relating to the development, commercialization and manufacture of KP106.

KP106 is a new chemical entity (NCE) comprised of d-amphetamine, and was identified utilizing KemPharm’s proprietary ligand activated therapy (LAT) approach. Phase 1 human clinical trial results demonstrated pharmacokinetics that predict a superior safety profile for KP106 as compared to Vyvanse®, a currently marketed amphetamine stimulant for ADHD. In addition, preclinical studies suggest that the prodrug properties of KP106 may offer unique abuse deterrent properties as compared with current amphetamine-based treatments for ADHD.

Under the terms of the exclusive collaboration agreement, MonoSol Rx, the developer of PharmFilm® technology and a drug delivery company specializing in rapid dissolving prescription film pharmaceutical products, has acquired the exclusive manufacturing rights for KP106. In exchange for these manufacturing rights and a right to receive a share of any royalties or other value associated with KP106, MonoSol Rx will be responsible for the majority of formulation costs and the manufacturing costs through commercial launch. KemPharm will retain controlling ownership of the commercial rights for KP106, while intellectual property rights created during the joint-development program will be shared by both companies.

“We are enthusiastic about the synergies that will result from this collaboration. Due to its abuse deterrent properties combined with its compliance film dosage form to address issues plaguing existing pediatric pill dosage forms, KP106 is poised to become the next generation ADHD therapy,” commented Travis Mickle, Ph.D., President and Chief Executive Officer, KemPharm.

“This collaboration is a natural strategic fit for MonoSol Rx and our PharmFilm® technology,” commented A. Mark Schobel, President and Chief Executive Officer, MonoSol Rx. “KemPharm is a true pharmaceutical innovator, and through the combination of KP106 and PharmFilm®, there is the potential to introduce a novel ADHD product that could represent a safer, more convenient treatment option for ADHD patients. We look forward to working together to maximize the commercial potential of KP106 through this partnership.”

For more information visit iowacityareadevelopment.com/.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Government/B2G Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Iowa City Area Development Group

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Government/B2G articles,
CATCH Visitors via Your Competitors Announcements!


KemPharm Launches Oral Film Dosage for ADHD

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Joe Raso - IowaCityArea.com 
319-354-3939 jraso[.]iowacityarea.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Iowa City Area Development Group securities in any jurisdiction including any other companies listed or named in this release.

Government/B2G via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Iowa City Area Development Group / Company Profile


Read Government/B2G Most Recent Related Press Releases:

DCNS Present At Exponaval 2016 from 29 November to 2 December, Chile
Resolver Named to Deloitte’s Technology Fast 50™ and Fast 500™ List for 2016
Social Security Announces 0.3 Percent Benefit Increase for 2017
Social Security Publishes Final Rule to Revise Medical Criteria for Evaluating Mental Disorders
DCNS Floats A New FREMM Frigate
DCNS Delivers the Second Mistral-class Helicopter Carrier to the Egyptian Navy, the LHD Anwar El Sadat
Resolver to Showcase Newest Command Center Applications Command Dispatch and Officer Mobile At The 62nd ASIS Annual Seminar and Exhibits
Social Security Board of Trustees - Long-Range Projection Unchanged for Trust Fund Reserve Depletion
DCNS Proud to Partner on Floating Maine’s Aqua Ventus Offshore Wind Project
Social Security Combats Homelessness and Helps Veterans Access Benefits

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  Triggr & Bloom

Visit  JobsWare.com







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today